I'd be comfortable to retain a base case pricing of US$2.5K given it also requires annual retreatment.
The thematic here is more than just the direct patient impact (which is dire) and driven from the top via Govt policy considerations based on the burden of OA to society which is is estimated to be $23B pa for Australia in isolation.
PAR Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)